SuperworthWest Pharmaceutical Services shares outstanding WST
Diluted shares outstanding, averaged over each quarter, from 2009.
- Latest quarter, to Jun 30, 2026
- 71.3M
- On a year earlier
- −1.7%
- fewer shares
West Pharmaceutical Services had 71.3M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 1.7% fewer than a year earlier, so each share owns a little more of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 72.7M | −1% |
| FY2024 | 73.4M | −2% |
| FY2023 | 74.7M | −1% |
| FY2022 | 75.5M | −3% |
| FY2021 | 77.8M | +2% |
| FY2020 | 76.4M | +1% |
| FY2019 | 75.7M | +0% |
| FY2018 | 75.4M | −1% |
| FY2017 | 75.8M | −0% |
| FY2016 | 75.9M | +2% |
| FY2015 | 74.4M | +1% |
| FY2014 | 73.7M | +1% |
| FY2013 | 72.9M | +4% |
| FY2012 | 70.3M | −5% |
| FY2011 | 74M | +1% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 71.3M | −2% | |
| Q1 FY26 | 72.4M | −1% | |
| Q4 FY25 | 72.7M | −1% | |
| Q3 FY25 | 72.6M | −1% | |
| Q2 FY25 | 72.5M | −2% | |
| Q1 FY25 | 73M | −2% | |
| Q4 FY24 | 73.4M | −2% | |
| Q3 FY24 | 73.4M | −3% | |
| Q2 FY24 | 73.7M | −2% | |
| Q1 FY24 | 74.3M | −2% | |
| Q4 FY23 | 74.7M | −1% | |
| Q3 FY23 | 75.3M | −1% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on West Pharmaceutical Services
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.